Thanks for the feedback. Nah they could actually start pre clinical models in other areas (as they have) without having iPPS approved for OA but they also need to be aware of spreading themselves too thin at this early stage though I'm guessing pre clinical model wouldn't consume too much $... With OA and MPS firmly as their focus, they prob. wouldn't really pursue anything new at scale at least until further along down the track in my view.
Don't forget once our funding is sorted and/or we have a big partner alongside, there will be potentially many more staff and $'s allocated to the pursuit of other such indications to really add to the future multilayering revenue potential.
PAR Price at posting:
$1.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)